{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:10:21Z","timestamp":1792285821723,"version":"4.4.0"},"reference-count":64,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mem. Inst. Oswaldo Cruz"],"DOI":"10.1590\/0074-02760230240","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T12:31:35Z","timestamp":1725280295000},"source":"Crossref","is-referenced-by-count":10,"title":["Leishmania spp. genetic factors associated with cutaneous leishmaniasis antimony pentavalent drug resistance: a systematic review"],"prefix":"10.1590","volume":"119","author":[{"given":"Raphaela Lisboa Andrade","family":"Nery","sequence":"first","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil; Universidade Federal da Bahia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaline Mabel Sousa","family":"Santos","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana Leandro","family":"Gois","sequence":"additional","affiliation":[{"name":"Escola Bahiana de Medicina e Sa\u00fade P\u00fablica,  Brazil; Universidade Federal da Bahia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldina","family":"Barral","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil; Universidade Federal da Bahia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Khouri","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil; Universidade Federal da Bahia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Alves","family":"Feitosa","sequence":"additional","affiliation":[{"name":"Escola Bahiana de Medicina e Sa\u00fade P\u00fablica,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0261-3495","authenticated-orcid":false,"given":"Luciane Amorim","family":"Santos","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil; Universidade Federal da Bahia,  Brazil; Escola Bahiana de Medicina e Sa\u00fade P\u00fablica,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","first-page":"22","article-title":"Control of the leishmaniases","volume":"949","year":"2010","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","article-title":"Cutaneous leishmaniasis a 2022 updated narrative review into diagnosis and management developments","volume":"23","author":"de Vries HJC","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/QCO.0000000000000579","article-title":"Cutaneous leishmaniasis in the 21st century from the laboratory to the bedside","volume":"32","author":"Barkati S","year":"2019","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft SL","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","DOI":"10.33448\/rsd-v10i7.16543","article-title":"Tratamento da leishmaniose, limita\u00e7\u00f5es da terap\u00eautica atual e a necessidade de novas alternativas uma revis\u00e3o narrativa","volume":"10","author":"Santiago AS","year":"2021","journal-title":"Res Soc Dev"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-4362.1990.tb04750.x","article-title":"Leishmaniasis currently recommended treatment","volume":"29","author":"Selim MM","year":"1990","journal-title":"Int J Dermatol"},{"key":"ref7","series-title":"Manual de vigil\u00e2ncia da leishmaniose tegumentar","year":"2017"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1592\/phco.2005.25.6.899","article-title":"Early-onset pentamidine-associated second-degree heart block and sinus bradycardia case report and review of the literature","volume":"25","author":"Antoniou T","year":"2005","journal-title":"Pharmacotherapy"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.actatropica.2019.01.009","article-title":"Meta-analysis and discussion on challenges to translate Leishmania drug resistance phenotyping into the clinic","volume":"191","author":"Sereno D","year":"2019","journal-title":"Acta Trop"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials new perspectives for old drugs","volume":"14","author":"Fr\u00e9zard F","year":"2009","journal-title":"Molecules"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.actatropica.2013.02.002","article-title":"Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil","volume":"126","author":"Torres DC","year":"2013","journal-title":"Acta Trop"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/QCO.0000000000000579","article-title":"Cutaneous leishmaniasis in the 21st century from the laboratory to the bedside","volume":"32","author":"Barkati S","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.actatropica.2017.08.017","article-title":"Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility","volume":"176","author":"Barrera MC","year":"2017","journal-title":"Acta Trop"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis a 21st century challenge","volume":"11","author":"Ponte-Sucre A","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref15","first-page":"1","article-title":"Plasticity of the Leishmania genome leading to gene copy number variations and drug resistance","volume":"5","author":"Papadopoulou B","year":"2016","journal-title":"F1000Res"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher D","year":"2015","journal-title":"Sys Rev"},{"key":"ref17","first-page":"105","article-title":"Checklist for analytical cross sectional studies","volume":"7","author":"Aromataris E","year":"2020","journal-title":"Joanna Briggs Institute Reviewer's Manual"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/0074-02760190111","article-title":"Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56\/ARM58 transcripts and reduced drug uptake","volume":"114","author":"Rugani JN","year":"2019","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"ref19","first-page":"145","article-title":"Molecular analysis of Aquaglyceroporin 1 gene in non-healing clinical isolates obtained from patients with cutaneous leishmaniasis from central of Iran","volume":"13","author":"Alijani Y","year":"2019","journal-title":"J Arthropod Borne Dis"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11686-021-00463-8","article-title":"Mitogen-activated protein kinase and Aquaglyceroporin gene expression in treatment failure Leishmania major","volume":"67","author":"Somee R","year":"2021","journal-title":"Acta Parasitol"},{"issue":"9","key":"ref21","first-page":"581","article-title":"Lancet Infect","volume":"7","author":"Reithinger R","year":"2007","journal-title":"Dis"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molbiopara.2015.07.003","article-title":"Generation of an aquaglyceroporin AQP1 null mutant in Leishmania major","volume":"201","author":"Plourde M","year":"2015","journal-title":"Mol Biochem Parasitol"},{"key":"ref23","first-page":"1","article-title":"Aquaglyceroporins and metalloid transport implications in human diseases","volume":"190","author":"Bhattacharjee H","year":"2009","journal-title":"Handb Exp Pharmacol"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/jac\/dkt442","article-title":"Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs","volume":"69","author":"Munday JC","year":"2014","journal-title":"J Antimicrob Chem"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.bbagen.2015.05.019","article-title":"A generic high-throughput assay to detect aquaporin functional mutants potential application to discovery of aquaporin inhibitors","volume":"1850","author":"To J","year":"2015","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0003476","article-title":"Intrachromosomal amplification, locus deletion and point mutation in the Aquaglyceroporin AQP1 gene in antimony resistant Leishmania (Viannia) guyanensis","volume":"9","author":"Monte-Neto R","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"29","key":"ref27","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1073\/pnas.1202593109","article-title":"Leishmania TDR1 structure, a unique trimeric glutathione transferase capable of deglutathionylation and antimonial prodrug activation","volume":"109","author":"Fyfe PK","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20040283","article-title":"Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1","volume":"381","author":"Denton H","year":"2004","journal-title":"Biochem J"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/tmi.13062","article-title":"Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates analysis of resistance biomarkers by gene expression profiling","volume":"23","author":"Oliaee RT","year":"2018","journal-title":"Trop Med Int Health"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-3024.2012.01361.x","article-title":"Characterization of Leishmania infantum thiol-dependent reductase 1 and evaluation of its potential to induce immune protection","volume":"34","author":"Silva AM","year":"2012","journal-title":"Parasite Immunol"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.meegid.2010.05.006","article-title":"Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes","volume":"10","author":"Torres DC","year":"2010","journal-title":"Infect Genet Evol"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1590\/S0100-879X2006000300006","article-title":"Glutathione and the redox control system trypanothione\/trypanothione reductase are involved in the protection of Leishmania spp against nitrosothiol-induced cytotoxicity","volume":"39","author":"Rom\u00e3o PRT","year":"2006","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0031182010001095","article-title":"Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony","volume":"138","author":"Adaui V","year":"2011","journal-title":"Parasitology"},{"issue":"4","key":"ref34","first-page":"749","article-title":"The expression profile of LmTRYP, LmTRYR, and LmHSP83 genes in treatment failure clinical isolates of Leishmania major","volume":"67","author":"Nourbakhsh A","year":"2021","journal-title":"Ann Parasitol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"106392","DOI":"10.1016\/j.actatropica.2022.106392","article-title":"Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of Iran","volume":"230","author":"Nateghi-Rostami M","year":"2022","journal-title":"Acta Trop"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1038\/s41598-021-93665-z","article-title":"Serine proteases profiles of Leishmania (Viannia) braziliensis clinical isolates with distinct susceptibilities to antimony","volume":"11","author":"Zabala-Pe\u00f1afiel A","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.actatropica.2013.02.002","article-title":"Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil","volume":"126","author":"Torres DC","year":"2013","journal-title":"Acta Trop"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/tmi.13062","article-title":"Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates analysis of resistance biomarkers by gene expression profiling","volume":"23","author":"Oliaee RT","year":"2018","journal-title":"Trop Med Int Health"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20040283","article-title":"Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1","volume":"381","author":"Denton H","year":"2004","journal-title":"Biochem J"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1379\/CSC-15R1.1","article-title":"The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite Leishmania","volume":"9","author":"Brochu C","year":"2004","journal-title":"Cell Stress Chaperones"},{"issue":"43","key":"ref41","doi-asserted-by":"crossref","first-page":"33883","DOI":"10.1074\/jbc.M003671200","article-title":"Inducible resistance to oxidant stress in the protozoan Leishmania chagasi","volume":"275","author":"Miller MA","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1574-695X.2009.00639.x","article-title":"Plasmodial heat shock proteins targets for chemotherapy","volume":"58","author":"Shonhai A","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00403-018-1872-2","article-title":"Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transport","volume":"311","author":"Mohebali M","year":"2019","journal-title":"Arch Dermatol Res"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1093\/emboj\/16.11.3057","article-title":"Co-amplification of the -glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae","volume":"16","author":"Grondin K","year":"1997","journal-title":"EMBO J"},{"issue":"2017","key":"ref45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exppara.2017.02.001","article-title":"Ornithine decarboxylase or gamma-glutamylcysteine synthetase overexpression protects Leishmania (Vianna) guyanensis against antimony","volume":"175","author":"Fonseca MS","year":"2017","journal-title":"Exp Parasitol"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/genes10110838","article-title":"Environmental conditions may shape the patterns of genomic variations in Leishmania panamensis","volume":"10","author":"Restrepo CM","year":"2019","journal-title":"Genes (Basel)"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3347\/kjp.2013.51.4.413","article-title":"Overexpression of ubiquitin and amino acid permease genes in association with antimony resistance in Leishmania tropica field isolates","volume":"51","author":"Kazemi-Rad E","year":"2013","journal-title":"Korean J Parasitol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpddr.2013.08.001","article-title":"Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp susceptible and resistant to antimony","volume":"3","author":"Moreira DS","year":"2013","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1046\/j.1365-2958.2002.02831.x","article-title":"Overexpression of the putative thiol conjugate transporter TbMRPA causes melarsoprol resistance in Trypanosoma brucei","volume":"43","author":"Shahi SK","year":"2002","journal-title":"Mol Microbiol"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molbiopara.2005.10.016","article-title":"The role of Trypanosoma brucei MRPA in melarsoprol susceptibility","volume":"146","author":"Alibu VP","year":"2006","journal-title":"Mol Biochem Parasitol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13071-021-04838-8","article-title":"Downregulation of FeSOD-A expression in Leishmania infantum alters trivalent antimony and miltefosine susceptibility","volume":"14","author":"Santi A","year":"2021","journal-title":"Parasit Vectors"},{"issue":"5","key":"ref52","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cimid.2013.05.004","article-title":"Leishmania infantum secreted iron superoxide dismutase purification and its application to the diagnosis of canine Leishmaniasis","volume":"36","author":"Longoni SS","year":"2013","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pt.2023.01.012","article-title":"Drug resistance in Leishmania Does it really matter?","volume":"39","author":"Domagalska MA","year":"2023","journal-title":"Trends Parasitol"},{"issue":"8","key":"ref54","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.meegid.2011.08.008","article-title":"Multilocus genotyping reveals a polyphyletic pattern among naturally antimony-resistant Leishmania braziliensis isolates from Peru","volume":"11","author":"Adaui V","year":"2011","journal-title":"Infect Genet Evol"},{"issue":"12","key":"ref55","first-page":"863","article-title":"Detection of drug resistance gene in cutaneous leishmaniasis by PCR in some endemic area of Iran","volume":"13","author":"Alizadeh R","year":"2011","journal-title":"Iran Red Crescent Med J"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.exppara.2013.07.018","article-title":"Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach","volume":"135","author":"Kazemi-Rad E","year":"2013","journal-title":"Exp Parasitol"},{"issue":"4","key":"ref57","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4103\/0972-9062.197272","article-title":"Aquaglyceroporin1 gene expression in antimony resistance and susceptible Leishmania major isolates","volume":"53","author":"Eslami G","year":"2016","journal-title":"J Vector Borne Dis"},{"issue":"9","key":"ref58","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/ijd.13321","article-title":"Expression analysis of activated protein kinase C gene (LACK1) in antimony sensitive and resistant Leishmania tropica clinical isolates using real-time RT-PCR","volume":"55","author":"Hajjaran H","year":"2016","journal-title":"Int J Dermatol"},{"issue":"2","key":"ref59","first-page":"168","article-title":"Expression analysis of multiple genes may involve in antimony resistance among Leishmania major clinical isolates from Fars Province, Central Iran","volume":"11","author":"Ghobakhloo N","year":"2016","journal-title":"Iran J Parasitol"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12639-018-1052-5","article-title":"J-binding protein 1 and J-binding protein 2 expression in clinical Leishmania major no response-antimonial isolates","volume":"43","author":"Ahmadian S","year":"2019","journal-title":"J Parasit Dis"},{"issue":"4","key":"ref61","first-page":"511","article-title":"Trypanothione reductase gene mutations in meglumine anti-moniate resistant isolates from cutaneous leishmaniasis patients using molecular dynamics method","volume":"15","author":"Fozongari F","year":"2020","journal-title":"Iran J Parasitol"},{"key":"ref62","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10969","article-title":"Molecular characteristic of treatment failure clinical isolates of Leishmania major","volume":"9","author":"Eslami G","year":"2021","journal-title":"PeerJ"},{"issue":"4","key":"ref63","first-page":"473","article-title":"Overexpression of iron super oxide dismutases A\/B genes are associated with antimony resistance of Leishmania tropica clinical isolates","volume":"17","author":"Bahrami A","year":"2022","journal-title":"Iran J Parasitol"},{"issue":"7","key":"ref64","first-page":"1","article-title":"Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56\/ARM58 transcripts and reduced drug uptake","volume":"114","author":"Rugani JN","year":"2019","journal-title":"Mem Inst Oswaldo Cruz"}],"container-title":["Mem\u00f3rias do Instituto Oswaldo Cruz"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0074-02762024000101121&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T12:32:37Z","timestamp":1725280357000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0074-02762024000101121&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":64,"alternative-id":["S0074-02762024000101121"],"URL":"https:\/\/doi.org\/10.1590\/0074-02760230240","relation":{},"ISSN":["1678-8060","0074-0276"],"issn-type":[{"value":"1678-8060","type":"electronic"},{"value":"0074-0276","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e230240"}}